Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 01, 2015 12:59 PM ET

Healthcare Providers and Services

Company Overview of ParagonRx International, LLC

Company Overview

ParagonRx International, LLC provides pharmaceutical risk management and optimizing medication use services for biopharmaceutical, pharmaceutical, and biotech companies. It offers risk management and REMS services, such as evidence-based analysis, REMS planning and design, regulatory preparations, implementation readiness, and operations and assessment services to support the strategy, design, development, documentation, approval, and implementation of risk management programs. The company also provides optimal product use services, including market landscape assessment, observational research, patient care process mapping, and product adoption programs; and strategic planning, organizationa...

2751 Centerville Road

Little Falls Centre Two

Suite 100

Wilmington, DE 19808

United States

Founded in 2001





Key Executives for ParagonRx International, LLC

Co-Founder, Chief Executive Officer, President and Principal
Co-Founder, Principal and Chief Medical Officer
Chief Executive Officer of InVentiv Health
Chief Medical Officer
Clinical Services Director
Compensation as of Fiscal Year 2015.

ParagonRx International, LLC Key Developments

ParagonRx Appoints Stephen W. Sun, MD, MPH as Chief Medical Officer

ParagonRx announced the appointment of Stephen W. Sun, MD, MPH, as Chief Medical Officer advising clients on regulatory and safety issues. The company reported that Dr. Sun, formerly with the U.S. Food and Drug Administration (FDA), will be reporting directly to ParagonRx President Jeffrey Fetterman. His appointment comes at a time of dramatic regulatory change in both the United States and globally. Regulators are under pressure to speed review of new medical products while simultaneously improving safety. As a consequence, drug developers and device makers planning for a successful review must be proactive in assuring optimal and safe use of products before the products come up for review. ParagonRx clients will have access to a savvy regulatory strategist in Dr. Sun, who understands the escalating scientific rigor regulators expect to see in filings. His public health experience also will benefit clients seeking counsel on the appropriate use of medications and devices designed to improve the well-being of large populations. After King Pharmaceuticals' acquisition of Alpharma, Dr. Sun served as King's Senior Director of Pharmacovigilance and Risk Management before moving on to further expand his industry experience in over-the-counter medications at Reckitt-Benckiser.

Similar Private Companies By Industry

Company Name Region
Midas Pharmaceuticals, Inc. United States
AIB Corp. United States
InterDent, Inc. United States
Dialysis Centers of America - Illinois, Inc. United States
Shore Pharmaceutical Providers Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ParagonRx International, LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at